Journal of International Oncology››2015,Vol. 42››Issue (4): 249-251.doi:10.3760/cma.j.issn.1673-422X.2015.04.003
Previous ArticlesNext Articles
Online:
2015-04-08Published:
2015-04-22Contact:
Cheng Yufeng, Email: qlcyf@163.comYANG Sheng-Si-;Cheng-Yu-Feng. Effect of three dimensional conformal radiotherapy combined with chemotherapy for advanced esophageal carcinoma[J]. Journal of International Oncology, 2015, 42(4): 249-251.
[1] Pramesh CS, Mistry RC. Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China[J]. Br J Surg, 2004, 91(4): 511 [2] Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14): 21372150. [3] 孙燕. 癌症三阶梯止痛指导原则[M]. 北京: 北京医科大学出版社, 2002: 100101. [4] Graham AJ, Shrive FM, Ghali WA, et al. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis[J]. Ann Thorac Surg, 2007, 83(4): 12571264. [5] 陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病与死亡[J]. 中国肿瘤, 2014, 23(1): 110. [6] Denham JW, Burmeister BH, Lamb DS, et al. Factors influencing outcome following radiochemotherapy for oesophageal cancer[J]. Radiother Oncol, 1996, 40(1): 3143. [7] 张彬, 乔田奎, 高彩霞. 同期适形放疗联合化疗治疗中晚期食管癌的临床研究[J]. 中国癌症杂志, 2011, 21(10): 803806. [8] Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of esophagus[J]. Cochrane Database Syst Rev, 2006, 25(1): CD002092. [9] 吴庆, 蒋建文. 顺铂和多西紫杉醇联合放疗治疗食管癌中的应用价值[J]. 当代医学, 2014, 20(8): 151152. [10] 鲁志兵. 同步放化疗对局部晚期食管癌患者的临床价值分析[J]. 中国医学创新, 2014, 11(5): 2122. [11] 周健. 紫杉醇联合顺铂、5FU 同步放化疗治疗晚期食管癌临床观察[J]. 临床合理用药, 2013, 6(1): 67. [12] 都振利, 位春红, 徐君. 多西他赛单药每周方案治疗老年晚期非小细胞肺癌的临床观察[J]. 肿瘤基础与临床, 2010, 23(2):171172. [13] 张汀荣, 赵韬, 徐昕, 等. 多西紫杉醇联合顺铂同期放疗治疗局部晚期食管癌的疗效及其毒副反应[J]. 中华肿瘤杂志, 2010, 32(10): 791794. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[4] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[5] | Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209. |
[6] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[7] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[8] | Yue Hongyun, Zhang Baihong.Differentiation therapies in human cancers[J]. Journal of International Oncology, 2024, 51(2): 109-113. |
[9] | Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104. |
[10] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[11] | Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[12] | Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma (2023 Edition)[J]. Journal of International Oncology, 2023, 50(7): 385-397. |
[13] | Li Chenxi, Zhao Hongwei.Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery[J]. Journal of International Oncology, 2023, 50(6): 342-347. |
[14] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[15] | Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||